Can We Improve Current Cancer Screening Programs?
نویسندگان
چکیده
منابع مشابه
Cancer Vaccines in Ovarian Cancer: How Can We Improve?
Epithelial ovarian cancer (EOC) is one important cause of gynecologic cancer-related death. Currently, the mainstay of ovarian cancer treatment consists of cytoreductive surgery and platinum-based chemotherapy (introduced 30 years ago) but, as the disease is usually diagnosed at an advanced stage, its prognosis remains very poor. Clearly, there is a critical need for new treatment options, and ...
متن کاملCervical cancer in Malaysia: can we improve our screening and preventive practice?
Background The 2010 WHO/ICO (Institut Catala d’Oncologia) summary report states that Malaysia has a population of 8.7 million women aged 15 years and above who are at risk of developing cervical cancer. Annually, 2126 women are diagnosed with cervical cancer and 631 die from the disease. The introduction of HPV vaccine in Malaysia has significantly encouraged the introduction of molecular era w...
متن کاملCan We Improve Patient Safety?
Despite greater awareness of patient safety issues especially in the operating room and the widespread implementation of surgical time out World Health Organization (WHO), errors, especially wrong site surgery, continue. Most such errors are due to lapses in communication where decision makers fail to consult or confirm operative findings but worryingly where parental concerns over the planned ...
متن کاملShould We Add Screening of Age-Related Macular Degeneration to Current Screening Programs for Diabetic Retinopathy?
The report by Chan et al in the current issue details how screening for both diabetic retinopathy and age-related macular degeneration (AMD) can be conducted using fundus photographs obtained with nonmydriatic cameras. Exactly how cost-effective is such a screening? Could this be a recommendation for the future? Herein, we explore the potential for such a model for the management of 2 of the le...
متن کاملScreening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?
Familial hypercholesterolemia (FH), an autosomal dominant atherosclerotic disease, is a common monogenic subtype of cardiovascular disease. Patients with FH suffer an increased risk of early onset heart disease. Early identification of abnormally elevated cholesterol signpost clinicians to interventions that will significantly decrease risk of related morbidity and mortality. Cascade genetic te...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Chemistry
سال: 2020
ISSN: 0009-9147,1530-8561
DOI: 10.1093/clinchem/hvaa078